Φορτώνει......
The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors
The baculovirus expression vector system (BEVS) platform has become an established manufacturing platform for the production of viral vaccines and gene therapy vectors. Nine BEVS‐derived products have been approved – four for human use (Cervarix®, Provenge®, Glybera® and Flublok®) and five for veter...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biotechnol J |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
WILEY‐VCH Verlag
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7159335/ https://ncbi.nlm.nih.gov/pubmed/25800821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.201400438 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|